UnitedHealth Group (NYSE:UNH) Stock Price Down 0%

UnitedHealth Group Incorporated (NYSE:UNHGet Free Report)’s stock price traded down 0% during mid-day trading on Friday . The company traded as low as $570.36 and last traded at $576.86. 1,370,091 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 4,005,205 shares. The stock had previously closed at $577.07.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on UNH shares. Wells Fargo & Company increased their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Robert W. Baird upped their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Royal Bank of Canada boosted their target price on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Monday. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Stock Down 0.3 %

The firm’s 50 day moving average price is $575.84 and its two-hundred day moving average price is $519.83. The company has a market capitalization of $531.20 billion, a P/E ratio of 35.26, a PEG ratio of 1.64 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the company earned $6.14 EPS. UnitedHealth Group’s revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in UNH. Macroview Investment Management LLC increased its position in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. True Wealth Design LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $31,000. Delos Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Signature Resources Capital Management LLC raised its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.